Is IRadimed Corporation overvalued?

IRadimed Corporation (IRMD) looks fairly valued — trading about 6% above its fair value.

Fairly valued

Price

$86.95

Fair value

$82.03

Current P/E

43.7

Normal P/E

41.2

Market cap

$1.11B

Dividend yield

1.4%

Return on equity

23.5%

Sector

Healthcare

Fair value compares IRMD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks